Delivery Order SPE2DB24D8003-SPE2DB25FJUCX
Award Date
4/2/25
Potential Completion Date
4/3/25
Potential Value
$3.6K
Federal Agency
Defense Logistics Agency
Awardee
Dakota Drug, Inc.
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Anoka, MN, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a federal contract award from the Defense Logistics Agency (DLA) to Dakota Drug, Inc., a self-certified small disadvantaged business. The $4,172.38 firm fixed price delivery order is for the supply of CONCERTA ER 36 MG TABLET 100S. The contract has a performance period through November 19, 2024 and is not designated as a set-aside. Dakota Drug, Inc. holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA under the ECAT Generation V Program, which allows the company to...
This is a federal contract award from the Defense Logistics Agency (DLA) to Dakota Drug, Inc., a self-certified small disadvantaged business, for the delivery of Concerta ER 54 mg tablets. The contract, valued at $3,485.12, has a firm fixed-price delivery order type and an ultimate completion date of October 17, 2024. This award is not associated with any set-aside program. Dakota Drug, Inc. holds a significant single-award Indefinite Delivery Contract (IDC) with the DLA, identified as...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Dakota Drug, Inc., a self-certified small disadvantaged business. The $5,924.06 firm fixed-price delivery order is for the supply of 4565891400 CONCERTA ER 18 MG TABLET 100S. The contract, which does not have a set-aside designation, has an ultimate completion date of September 23, 2024. Dakota Drug, Inc. also holds a larger $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop...
This is a federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical division to Dakota Drug, Inc., a self-certified small disadvantaged business. The $23,774.87 Firm Fixed Price delivery order contract is for the delivery of 4562940892 CONCERTA ER 27 MG TABLET 100S. The award is not associated with a set-aside program and has an ultimate completion date of November 30, 2023. Dakota Drug, Inc. holds a significant $999,999,999.00 single-award Indefinite Delivery Contract...
This is a federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical to Dakota Drug, Inc., a self-certified small disadvantaged business operating as a for-profit subchapter S corporation. The contract, valued at $10,797.75, is a firm fixed-price delivery order without a set-aside designation. It covers the supply of 4,564,879,318 units of CONCERTA ER 36 MG TABLET 100S, a prescription medication, to support the medical supply chain operations for the U.S. Armed...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Dakota Drug, Inc., a self-certified small disadvantaged business located in Anoka, Minnesota. The $5,384.21 firm fixed-price delivery order is for the supply of 4568234805 - CONCERTA ER 18 MG TABLET 100S, with a completion date of May 14, 2025. Dakota Drug, Inc. holds a larger Indefinite Delivery Contract (IDC) with the DLA, valued at $999,999,999.00, as part of the DLA Troop Support Medical's ECAT Generation V...
This federal contract award to Dakota Drug, Inc. is a delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical, with a ceiling value of $12,427.91. The contract is for the delivery of Concerta ER 27 mg tablets, and is structured as a firm fixed-price agreement without any set-aside designation. Dakota Drug, Inc. is the prime contractor for this award, and is a self-certified small disadvantaged business operating as a for-profit subchapter S corporation. The company...
This federal contract award, valued at $5,702.38, was issued by the Defense Logistics Agency (DLA) to Dakota Drug, Inc., a self-certified small disadvantaged business operating as a for-profit subchapter S corporation. The contract is for the delivery of CONCERTA ER 27 MG TABLET 100S, a prescription medication. This award is a delivery order under the DLA Troop Support Medical's ECAT Generation V Program, a larger indefinite delivery contract (IDC) valued at $999,999,999.00 that allows Dakota...
This is a delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical division to Dakota Drug, Inc., a self-certified small disadvantaged business. The $12,991.31 firm fixed price contract is for the delivery of 100 units of the prescription medication Concerta ER 54 mg tablets. The contract does not have a set-aside designation. Dakota Drug, Inc. is a key supplier to the DLA, holding a significant $999,999,999.00 Indefinite Delivery Contract (IDC) under the DLA Troop...
This federal contract award, identified as SPE2DX15D8003|SPE2DX24F7B3Y, was granted to Dakota Drug, Inc., a self-certified small disadvantaged business, by the Defense Logistics Agency (DLA) Troop Support Medical division. The contract, valued at $17,482.96, is for the delivery of Concerta ER 18 mg tablets in 100-count bottles. This is a firm fixed-price delivery order contract with an ultimate completion date of October 12, 2023. Dakota Drug, Inc. is a key supplier for the DLA, holding a...